Washington, May 26 -- Congresswoman Debbie Dingell issued the following press release:
U.S. Representatives Debbie Dingell (D-MI-06) and Rich McCormick (R-GA-07) requested the Food and Drug Administration (FDA) to reconsider its policy on screening human tissue donors for sepsis. In a letter to Kyle A. Diamantas, Acting Commissioner of the FDA, Representatives Dingell and McCormick asked that the FDA consider adopting the approach of screening for systemic infection, rather than sepsis diagnosis, before finalizing the draft guidance document "Recommendations to Reduce the Risk of Transmission of Disease Agents Associated with Sepsis by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)" ("sepsis guidance").
A copy of th...